Anesthesia & Analgesia:
CRITICAL CARE AND TRAUMA: Review Article
Splanchnic Blood Flow in Low-Flow States
Jakob, Stephan M. MD, PhD
Department of Intensive Care Medicine, University Hospital, Bern, Switzerland
Supported in part by Schweizerischer Nationalfonds Grant #32-61988.00.
November 19, 2002.
Address correspondence and reprint requests to Stephan Jakob, Department of Intensive Care Medicine, University Hospital “Inselspital,” Bern, CH-3010 Bern, Switzerland. Address e-mail to email@example.com.
Since the establishment of the pathophysiologic concept that low splanchnic blood flow leads to increased mucosal permeability, endotoxemia, and local and distant organ failure (1–6), the adequacy of splanchnic perfusion has become a major concern in the most critically ill patients, such as trauma victims or patients in septic or circulatory shock. However, recent trials have shown that hepatosplanchnic perfusion and oxygenation are at risk even during routine interventions in the intensive care unit (7) and during established surgical procedures such as cardiac surgery (8,9). In these patients, hepatosplanchnic cellular damage can occur (8,9).
Although the administration of crystalloids may improve hepatosplanchnic perfusion in preoperative cardiac surgical patients (10,11), this seems not to be true for patients with other forms of circulatory failure (12). Moreover, the administration of crystalloid and colloid solutions based on saline can actually result in metabolic acidosis and impaired gastric mucosal perfusion (13). The effects of drugs on hepatosplanchnic blood flow may differ from their effects on the systemic circulation (14). In addition, drugs may also interfere with hepatosplanchnic metabolism (15). The aim of this review is to alert the anesthesiologist to the consequences of both impaired systemic blood flow and its treatment on splanchnic perfusion and metabolism. The review discusses pathophysiological aspects of blood flow regulation under different clinical and experimental conditions associated with impaired splanchnic blood flow. Recently published trials on the effects of various drugs with the potential to alter hepatosplanchnic perfusion are briefly reviewed.
Hepatosplanchnic Circulation and Function Under Low-Flow Conditions
Under various conditions of low systemic perfusion—e.g., hypovolemia, hemorrhage, and circulatory shock—blood flow to vital organs is maintained at the expense of the perfusion of visceral organs (16–21). However, the findings are conflicting: we (22) and others (23) have provided evidence that blood flow to the splanchnic region is reduced in proportion to systemic blood flow under different conditions of low systemic blood flow. Moreover, the splanchnic organs are not among the first to produce lactate when systemic blood flow decreases (22). Varying study conditions and consequent pathophysiological reactions can explain such inconsistent findings.
The splanchnic region has a large capacity to increase oxygen extraction (24). At least over the short term, the metabolic processes can be maintained at a high level of oxygen extraction in low-flow states. Prolonged impaired perfusion of the splanchnic organs results in ischemia, tissue damage, and necrosis. As a result of splanchnic ischemia, mucosal permeability increases (25), and endotoxin and other bacterial products can pass through the gut wall into lymph nodes and blood vessels (26–28) and thereby cause injury to local and distant organs (6,29). In addition, leukocyte-activating factors are released during both splanchnic ischemia and reperfusion (30). Multiple organ failure and death have been associated with such changes (3,5). However, studies have failed to demonstrate the complete sequence of events in patients. Nevertheless, there is a strong association between low gastric mucosal pH and increased morbidity and mortality in critically ill patients (5,31–33).
Regulation of Hepatosplanchnic Blood Flow
Both intrinsic and extrinsic mechanisms regulate the intestinal blood flow (34). Intrinsic factors include local myogenic and metabolic control, locally produced vasoactive substances, and local reflexes. The intrinsic factors are responsible for phenomena such as pressure/flow autoregulation, reactive hyperemia, and hypoxic vasodilation (34). Extrinsic factors are circulating vasoactive substances, sympathetic innervation, and systemic hemodynamic changes. Infusion of drugs acting on α-adrenergic receptors results in intestinal vasoconstriction, whereas pharmacological stimulation of β-adrenergic receptors is associated with intestinal vasodilation. Angiotensin, vasopressin, and endothelin are potent intestinal vasoconstrictors (35–37). In low-flow states, activation of the renin-angiotensin axis is a predominant feature of splanchnic vasoconstriction (38–42). Mesenteric angiotensin II-mediated vasoconstriction can be inhibited by pharmacological maintenance of perfusion pressure with sodium nitroprusside (43). In this study, incremental doses of angiotensin II in pigs caused a strong dose-dependent vasoconstriction (increases in vascular resistance of up to of 90% and 110% in the mesenteric and renal vascular beds, respectively). When sodium nitroprusside was infused at doses titrated to keep the mean arterial blood pressure constant during concurrent angiotensin II administration, angiotensin II-induced vasoconstriction was inhibited in the mesenteric but not in the renal circulation. As the authors of the article state (43), this can be explained by differences between the vascular beds in the relative regional balance between nitric oxide-mediated vasodilation and angiotensin II-induced vasoconstriction. Alternatively, coexisting local myogenic pressure-dependent vasoconstriction may be different in the renal and mesenteric regions.
Despite the theoretical benefit of angiotensin-converting enzyme inhibition and/or infusion of sodium nitroprusside in conditions in which mesenteric blood flow is low, the systemic effects of these drugs often prohibit their administration in cardiogenic shock and hypovolemia.
The Hepatic Arterial Buffer Response
It is believed that the liver is relatively protected in states of low gut blood flow. The hepatic arterial buffer response (HABR)—a dynamic interaction between hepatic arterial and portal venous blood flow (44–46) —tends to maintain total hepatic blood flow when portal blood flow decreases (Fig. 1). The compensation of hepatic arterial blood flow for the decreased portal venous blood flow is roughly 20%–30%(44–46). The compensation in terms of oxygen delivery is substantially higher because of the higher oxygen content in the hepatic artery as compared with the portal vein. Adenosine is involved in the underlying physiological mechanism of the HABR (Fig. 2) (48). It is hypothesized that the adenosine in Mall’s space is washed out when portal venous blood flow is normal, but not when it is low. Under these circumstances, accumulating adenosine causes hepatic arterial vasodilation (44).
Most of the experiments for the assessment of the HABR have been performed in splenectomized animals (44,46,48–51). Splenectomy is performed to avoid an increase in circulating splanchnic blood volume when the spleen is contracted in response to decreasing mesenteric perfusion. Hence, splenectomy would be most useful in animals with large spleens and contractile splenic capsules (such as dogs). For easier assessment of blood flow changes, branches from the celiac trunk other than the hepatic arteries are often ligated, and branches to the portal vein are excluded from the circulation. This procedure has a major effect on blood flow distribution and probably also on blood flow regulation during decreasing portal venous blood flow. The HABR has been evaluated mainly during acute mesenteric artery occlusion in animals with normal cardiac output (44,46,49,50). This model represents clinical syndromes such as mesenteric embolism or mesenteric or portal venous thrombosis. However, systemic hemodynamics may have an effect on the HABR (22). We have recently demonstrated that the hepatic arterial blood flow compensation disappears during cardiac tamponade (22). The HABR is also exhausted during continuous endotoxin infusion (52) and in CO2 pneumoperitoneum (53). Hence, it appears that the protection of liver oxygenation and perfusion is lost during low systemic blood flow and other conditions of reduced visceral organ blood flow. This may explain the early appearance of hepatic failure under these conditions.
Effects of Underlying Mechanisms of Impaired Splanchnic Blood Flow on Hepatosplanchnic Blood Flow Regulation
Hypovolemia and Hemorrhage.
During hemorrhage in humans, total splanchnic blood flow decreases in proportion to cardiac output (23). In contrast, local microcirculatory blood flow in the gastrointestinal region is heterogeneously distributed during acute hemorrhage (54): in this animal study, the microcirculatory flow in the jejunal mucosa was better preserved than in the gastric mucosa, whereas the microcirculation of the pancreas was disproportionately impaired, indicating the presence of particularly vulnerable splanchnic organs. There is evidence that total splanchnic blood flow, if once decreased, may remain low for an extended period: in volunteers, simulated transient hypovolemia by prolonged application of lower-body negative pressure caused a parallel decrease in systemic, splanchnic, and musculocutaneous blood flow (55). Each cardiovascular and biological variable had returned to baseline values after 60 min of recovery except splanchnic blood flow, which remained below baseline values. In contrast, transiently decreased splanchnic blood flow during hemodialysis with ultrafiltration returned rapidly to baseline values (7). In these patients, the transient, threefold increase in renin concentration during hemodialysis likely indicates hypovolemia-induced impairment of renal perfusion. Differences in the effective circulating blood volume and renal function between the volunteers and the patients, and changes in serum osmolality during and after hemodialysis, may explain the discrepancies.
During hemorrhage (10 mL/kg body weight), the HABR is maintained (48). Liver oxygen supply does not decrease until the blood loss exceeds 30%(56), suggesting blood flow redistribution within the splanchnic region, with impaired perfusion of extrahepatic branches of the celiac trunk. It is speculative whether similar pathophysiological effects explain the coexistence of low cardiac output, low splanchnic blood flow, maintained splanchnic oxygen consumption, and gastric mucosal acidosis in patients after cardiac surgery (57–59).
During hypovolemia, total hepatosplanchnic perfusion can therefore be estimated from systemic blood flow, but one has to bear in mind that splanchnic blood flow may remain decreased when systemic hemodynamics have been restored. In addition, on a local level, visceral perfusion may be disproportionately diminished.
Isovolemic hemodilution is another mechanism by which blood flow is redistributed within the splanchnic region: in one experiment, acute isovolemic hemodilution with hydroxyethyl starch to a hematocrit of 20% resulted in an 86% increase in hepatic arterial blood flow and a 28% increase in portal venous blood flow (60). In the same experiment, small-intestine mucosal perfusion increased by 68%, whereas blood flow to the nonmucosal tissue compartment of the gut wall increased by 32%. Different rheological properties in the respective microcirculation can explain these discrepancies. Redistribution of blood flow during isovolemic anemia may form the basis for preservation of tissue oxygenation and function in certain organs (61).
Ischemia of abdominal visceral organs is associated with the activation of visceral afferent sympathetic C fibers and a concomitant reflex increase in arterial blood pressure, heart rate, and cardiac contractility (62). The afferent sympathetic nerve endings respond to severe hypoxia, as well as to bradykinin and prostaglandins (63). Celiac and superior mesenteric ganglionectomy diminish the cardiovascular reflexes (62). Occlusion of both the celiac trunk and the superior mesenteric artery produces additive effects, but the occlusion of the latter artery is associated with a more profound cardiovascular reflex (64). This occurs despite the fact that the celiac trunk supplies a larger organ mass as compared with the superior mesenteric artery and is possibly related to the greater reduction in tissue pH and the increase in venous lactate concentration from the ischemic vascular bed in the superior mesenteric artery-supplied organs (64). Local regulatory mechanisms compensate for an acute reduction in regional splanchnic perfusion, and the reduction in blood flow is therefore less than would be proportional to the reduction in perfusion pressure (62). In animals, up to 5 h of intestinal ischemia did not produce systemic signs of hypoperfusion, such as a decrease in base excess or altered hemodynamic and oxygen-related variables (65). Also, subsequent 40%, 70%, and 100% occlusion of the superior mesenteric arterial blood flow for 1 h each did not result in increased mixed-venous arterial Pco2 gradients despite intramucosal acidosis, increased splanchnic oxygen extraction, and increased portal venous-arterial lactate gradients (66).
We have measured the HABR under conditions of selectively, severely reduced mesenteric blood flow in pigs (67). The absolute increase in hepatic arterial blood flow in response to portal vein occlusion decreased significantly during 2 h of ischemia. In control animals, the HABR became less effective but was not exhausted. Reperfusion restored the HABR partially. Possibly, repeated ischemia/reperfusion events caused by testing the buffer response interfered with hepatic adenosine production or transport. Alternatively, the effects of surgery, anesthesia, or both may have contributed to the observed changes in both groups of animals.
In summary, isolated mesenteric hypoperfusion, e.g., as a consequence of mesenteric embolism or portal venous thrombosis, may not become clinically apparent because of regional blood flow redistribution and local regulatory mechanisms. The exhaustion of the HABR in conditions in which splanchnic blood flow is low also has important clinical implications. If the hepatic arterial blood flow has already increased in response to a decreasing mesenteric blood flow, it may not compensate for an acute further impairment of mesenteric flow.
Acute Circulatory Failure.
In experimental circulatory shock, a decrease in blood flow to vital organs may be attenuated by a concomitant disproportionate decrease in perfusion of visceral organs (16,38–41). In patients with low cardiac output after cardiac surgery (57,58), and during experimental, euvolemic cardiac tamponade (22), splanchnic blood flow is reduced in proportion to cardiac output. Moreover, mesenteric lactate production occurs late during tamponade (22). It is important to realize that in the carefully designed and conducted experiments by Bailey et al. and Bulkley et al. (16,38–41), low systemic blood flow was achieved by a combination of hemorrhage and cardiac tamponade, and blood flow was measured from single regional splanchnic vessels, i.e., from the inferior mesenteric artery (16,40), the celiac trunk (38), the superior mesenteric artery (39), or the hepatic artery or portal vein (41). The authors combined hemorrhage and cardiac tamponade because they realized that prior hemorrhage sensitized the animals to subsequent tamponade. In these experiments, cardiac output was reduced to <40% of baseline levels. Fractional regional splanchnic blood flow decreased only at the lowest level of cardiac output (40).
We have measured regional splanchnic perfusion (blood flow from the superior mesenteric artery, celiac trunk, hepatic artery, and portal vein) and the HABR during moderate and more severe cardiac tamponade (decreases in cardiac output by 20% and 55%, respectively) in euvolemic pigs (22). During severe tamponade, all regional blood flows decreased. While fractional superior mesenteric blood flow remained constant, fractional hepatic arterial blood flow increased during moderate tamponade and remained unchanged thereafter. The acute compensation of hepatic arterial blood flow for a decrease in portal venous flow—the HABR—disappeared during tamponade. These data demonstrate that the liver is only initially protected during low systemic perfusion. Later, the HABR is exhausted. Because fractional splanchnic blood flow was preserved in these euvolemic animals, the splanchnic organs were not among the first to produce lactate during tamponade (unlike the lungs, where lactate production occurred early) (22). In contrast, the capacity of the liver to increase lactate uptake was exhausted early (22).
There are different forms of acute circulatory failure, and their effect on hepatosplanchnic perfusion may vary. For example, right ventricular failure with increased central venous pressure is associated with hepatic ischemia (68,69). This is in contrast to shock without cardiac insufficiency (68). In this recent retrospective analysis, 31 patients with ischemic hepatitis not related to trauma were identified. Ischemic hepatitis was defined as an acute, reversible increase in either serum alanine or aspartate aminotransferase of at least 20 times the upper limit of normal, excluding known causes of acute hepatitis or hepatocellular injury, in patients with documented systolic blood pressures <75 mm Hg for at least 15 min. These patients were compared with a cohort of another 31 previously healthy patients who sustained major nonhepatic trauma and in whom similar hypotensive episodes were documented. Despite the marked reduction in blood pressure, no patient in the control group developed ischemic hepatitis. All 31 patients with ischemic hepatitis had evidence of underlying organic heart disease, and 29 of these (94%) had right-sided heart failure. Hence, right-sided heart failure, with resultant hepatic venous congestion, seems to predispose the liver to hepatic injury during periods with low blood pressure.
In conclusion, depending on the pathophysiology of acute circulatory failure, splanchnic blood flow may be reduced proportionately or disproportionately to systemic perfusion. Although in the presence of both low systemic blood flow and hypovolemia, splanchnic blood flow is preferentially reduced, patients in shock with concomitant right ventricular failure are at high risk of developing severe liver dysfunction. In these patients, preservation of a certain perfusion pressure across the hepatosplanchnic region may become a therapeutic target to achieve rather than the absolute systemic blood pressure.
Isolated Visceral Hypoperfusion.
To eliminate systemic effects such as congestion on hepatosplanchnic perfusion, we have recently developed a new model for isolated visceral hypoperfusion (70,71). Blood flow to the abdominal organs was selectively reduced by using an extracorporeal circuit between the proximal abdominal aorta (inflow limb just below the diaphragm) and the distal abdominal aorta (outflow limb beyond the kidney arteries) (70,71). Twenty-four pigs were randomized to a control group and a low-flow group (12 in each group). Ultrasound flowprobes were placed around the celiac trunk, the superior mesenteric artery, the portal vein, the hepatic artery, and the left kidney artery. Laser Doppler flowprobes were fixed on the surface of the liver, the left kidney, and the gastric and jejunal mucosa. The induction of the shunt was associated with a proportional decrease in all visceral blood flows, whereas the changes in the mucosal perfusion were heterogeneous. The overall correlation between the regional and the respective mucosal and surface blood flows was weak. These data demonstrate that local splanchnic mucosal and serosal blood flow distribution occur independently of regional blood flow changes. The heterogeneity of local splanchnic blood flow distribution is a phenomenon that seems to occur independently of the underlying mechanism for impaired splanchnic perfusion (54,72). It may provide a basis for maintenance of splanchnic oxygenation in local splanchnic tissues.
Cardiopulmonary Bypass (CPB).
CPB is associated with a systemic inflammatory response (73–75) and with increased gastrointestinal permeability (76,77). Hyperpermeability of the intestinal wall as a consequence of CPB may be related to a certain degree of ischemia/reperfusion, inflammation, or both (29,78). CPB and the associated neuroendocrine and inflammatory changes induce a progressive increase in systemic vascular resistance that extends into the early postoperative phase (79,80). Reduced organ perfusion and increased left ventricular work are potential consequences. During hypothermic (27°C–29°C), pulsatile CPB (blood flow 2.1–2.8 L · min−1 · m−2) in humans, total hepatic blood flow decreases by an average of 20%(81). In contrast to hepatic blood flow, gastrointestinal blood flow did not decrease in animals during normothermic (82) or hypothermic (83) CPB. However, changes in large-intestinal blood vessels do not reflect hemodynamic changes in microvascular beds (82,83). Gastrointestinal mucosal blood flow may decrease by 50% both during hypothermic (28°C) (76,83) and normothermic (82) CPB, despite unchanged or even increasing superior mesenteric arterial blood flow (82,83). Worsening gastric mucosal acidosis has also been measured postoperatively during the rewarming phase (76).
CPB and the subsequent rewarming phase are therefore other conditions with impaired hepatosplanchnic perfusion. Especially gastric and gut mucosal blood flow are reduced, and increased permeability and endotoxemia are common (77). Although no drug is available that selectively improves splanchnic perfusion in a clinically significant way, perioperative volume loading seems to prevent or ameliorate mucosal acidosis and outcome (11). In addition, enteral nutrition after cardiac surgery is associated with increased systemic and splanchnic blood flow, even in patients requiring hemodynamic support (84). This indicates an adequate hemodynamic response to early enteral feeding.
During infection and severe systemic inflammation, splanchnic metabolic demands increase (85–89). Because splanchnic oxygen consumption increases to a greater extent than splanchnic blood flow in hyperdynamic septic states, oxygen extraction increases. In septic shock, in which early myocardial depression is common, splanchnic tissue perfusion is at risk. Sepsis and endotoxemia are associated with major changes in systemic and regional blood flows and blood flow regulation (87,90–92). Early in endotoxemia, lung, intestinal, hepatic arterial, celiac trunk, and portal venous vascular resistances increase, and the HABR is abolished (52,90–93). Later, the regional vascular resistances decrease, but not uniformly (52), and the HABR recovers with an increased hepatic arterial resistance for a given portal flow (91). Endotoxic shock is associated with early (after 30 min) and late (after 240 min) impairment of portal venous blood flow, increased splanchnic blood pooling, and a subsequent decrease in cardiac output (91).
Splanchnic microcirculatory blood flows are heterogeneously distributed in septic shock, and the changes cannot be predicted from changes in systemic or regional hemodynamics (72). During endotoxemia, superficial hepatic blood flow decreases, whereas jejunal mucosal blood flow increases (94). When blood flow is reduced by cardiac tamponade, endotoxin-treated animals have a greater whole-body and regional critical oxygen delivery and a lower whole-body, liver, and intestinal critical oxygen extraction ratio than control animals (94). This emphasizes impaired oxygen extraction capabilities, possibly due to maldistribution in microcirculation, in septic states. Hepatic perfusion and oxygenation are therefore especially at risk in septic shock because of a combination of diminished portal blood flow, impaired or exhausted HABR, and decreased oxygen extraction capability.
Trauma and Abdominal Compartment Syndrome.
Several direct and indirect consequences of trauma may impair splanchnic blood flow, including direct abdominal injury, hemorrhage, increased intrathoracic pressure, or cardiac tamponade, with resulting impaired venous return and increased intraabdominal pressure. There is some evidence that angiotensin-converting enzyme inhibitors may improve the adequacy of gastric mucosal perfusion in patients after trauma (95). However, the lack of a control group in this study makes the interpretation of the results difficult.
Effects of Drugs in Low Splanchnic Blood Flow States: Recent Trials
Once splanchnic ischemia is detected, treatment is not straightforward. No drugs are available that can selectively and completely restore impaired splanchnic blood flow. However, a number of drugs may actually worsen splanchnic perfusion, decrease metabolism, or both (96,97). Because dopamine and β2 receptors are expressed to a great extent on mesenteric vessels, drugs with affinity to these receptors have been predominantly studied in trials of hepatosplanchnic perfusion. Recently, systemic and splanchnic hemodynamic effects of fenoldopam, a dopamine-1 receptor agonist, were studied during hemorrhage (98). Fenoldopam restored portal vein blood flow to near baseline, maintained fractional splanchnic blood flow, and attenuated the increase in ileal mucosal Pco2. In addition, fenoldopam redistributed the blood flow away from the serosal to the mucosal layer, both at baseline and during hemorrhage. Whether fenoldopam improves splanchnic perfusion in patients with low systemic blood flow originating from conditions other than hemorrhage has not yet been demonstrated.
The effects of dobutamine and enoximone, a phosphodiesterase inhibitor, were compared in patients with intravascularly fluid-resuscitated septic shock (99). Liver blood flow was estimated by using the continuous indocyanine green infusion technique and hepatic venous catheterization. Liver function was assessed by using monoethylglycinexylidide formation after lidocaine injection, and inflammation was quantified as the release of hepatic tumor necrosis factor-α. Cardiac output and splanchnic blood flow increased in both groups after 12 and 48 h of the respective drug infusion. In dobutamine-treated patients, the fractional hepatosplanchnic blood flow decreased slightly, whereas it remained unchanged in the enoximone group. Hepatosplanchnic oxygen consumption and release of tumor necrosis factor-α were increased in both groups after 12 h of vasoactive drug infusion, but arterial monoethylglycinexylidide (MEGX) concentrations increased only in the enoximone group. Methodological problems in this study, such as a lack of control patients and incomplete assessment of MEGX kinetics, make it difficult to draw conclusions as to the superiority of one of the drugs in terms of better preservation of liver function or attenuation of inflammation.
The effects of dobutamine and dopamine were compared during CO2 laparoscopy with increased intraabdominal pressure (100). In general, moderate increases in intraabdominal pressure do not lead to overt complications. However, laparoscopy is performed increasingly in older and sicker patients, in whom the procedure may take longer. Under those circumstances, clinical impairments in renal and hepatic function have been described (101). Despite restoration of gut mucosal perfusion and improved hepatic arterial blood flow with small doses of dobutamine, total hepatosplanchnic blood flow could not be maintained with either dobutamine or dopamine.
Dopamine is used to support cardiac output and blood pressure in patients with cardiac failure and septic shock (102,103). We measured the effects of dopamine on systemic and splanchnic blood flow and metabolism in septic and cardiac surgery patients (97). Dopamine infusion was started at a dose of 1 μg · kg−1 · min−1 and then gradually increased until the thermodilution cardiac output was 25% higher than at baseline. Dopamine infusion was associated with a parallel increase in systemic and splanchnic blood flow. Although systemic oxygen consumption did not change in either group of patients, splanchnic oxygen consumption decreased in septic patients and increased in cardiac surgery patients. A decrease in splanchnic oxygen consumption during dopamine infusion has also been reported in patients with acute hepatic failure (104). Blood flow redistribution could explain a reduction of hepatosplanchnic oxygen uptake despite an increase in regional perfusion. Alternatively, some metabolic functions of the hepatosplanchnic region may have been impaired. Dopamine may directly inhibit isoenzymes of the cytochrome P450 complex (105). Different baseline activities of P450 isoenzymes may account for the inverse effects of dopamine infusion on splanchnic oxygen consumption in the two patient groups. The indications and safety of dopamine in sepsis should therefore be reevaluated.
Dopexamine may improve splanchnic tissue oxygenation during major abdominal surgery (106). However, the beneficial effects seem to be restricted to certain sites of the gut. Whereas the Po2 on the serosal side of the small bowel increased during dopexamine infusion, the gastric mucosal-arterial Pco2 gradient as a measure of the adequacy of local perfusion did not improve (106). In addition, severe tachycardia associated with dopexamine may limit its usefulness.
Because endothelin is a potent splanchnic vasoconstrictor, inhibition of endothelin-1 receptors may be useful to increase splanchnic blood flow. In experimental acute cardiac failure, endothelin-1 blockade improved mesenteric but not renal perfusion (107). Endothelin-1 blockade also restored mucosal blood flow and oxygenation. These results illustrate the regional importance of endothelin-1-induced vasoconstriction. Considering the implications of improved mucosal perfusion in terms of maintenance of mucosal barrier integrity, endothelin blockade may be helpful in low-output states. However, the usefulness of endothelin blockade has yet to be demonstrated in clinical studies. These trials suggest that some drugs may be beneficial for the perfusion of certain areas within the visceral circulation. However, there may also be adverse effects, such as depressed metabolism, and the overall benefits of such drugs have not been evaluated properly thus far.
Effects of Drugs for Restoration of Blood Pressure on Splanchnic Blood Flow
The goals of drug infusion in patients with hypotension are to increase preload, myocardial contractility, heart rate, and vascular resistance or to achieve a combination of any of these. If blood pressure increases as a result of an increased vascular resistance, splanchnic blood flow may be at risk. In a trial, titrating norepinephrine (to a mean arterial blood pressure of 65, 75, and 85 mm Hg) in patients with septic shock did not affect splanchnic blood flow, and cardiac output increased by 15%–20%(108). Similarly, a reduction of norepinephrine dose and fluid administration did not alter absolute or fractional splanchnic blood flow in septic shock (12). In patients with acute hepatic failure, increasing systemic blood pressure from 68 to 85 mm Hg with dopamine (5 μg · kg−1 · min−1) resulted in a similar increase in cardiac output and splanchnic blood flow (104). Vasopressin has been recommended in the treatment of adult patients with ventricular fibrillation. The effect of vasopressin on total hepatosplanchnic blood flow has not yet been studied in humans. In a pig model of cardiopulmonary resuscitation, vasopressin-treated animals survived, whereas all animals that received epinephrine died (109). During and after resuscitation from cardiac arrest in animals, both renal and splanchnic blood flow may be critically impaired, especially when vasopressin is used (110–112). A reduction in portal and total hepatosplanchnic blood flow, respectively, has also been described with the use of terlipressin in animals (113) and in patients with liver cirrhosis (114).
It is not known whether the vasopressin-induced shift in blood flow during cardiopulmonary resuscitation from the muscle, skin, and gut towards the brain and myocardium has deleterious effects for the splanchnic region and whether this may lead to multiple organ failure once spontaneous circulation has been reestablished. Hence, the liberal use of vasopressin or one of its analogs is not recommended at the moment. In contrast, dopamine and norepinephrine at doses sufficient to achieve arterial blood pressure of 65 to 85 mm Hg in septic shock do not seem to impair total hepatosplanchnic blood flow.
Inadequate splanchnic perfusion in critically ill patients is associated with increased morbidity and mortality. The underlying pathophysiological mechanisms are still not well understood. Insufficient splanchnic blood flow may result from a multitude of different diseases, treatment modalities, and their interplay. It is therefore important to realize under which experimental or clinical conditions the effects of vasoactive drugs on splanchnic blood flow are assessed. Unfortunately, many of the available monitoring tools for hepatosplanchnic perfusion and metabolism are difficult to apply in the clinical setting, and the interpretation of the obtained results is not straightforward. Hence, splanchnic resuscitation concepts have not been established. Future research projects should focus on the interplay among the physiological regulatory mechanisms in splanchnic organs, disease, and treatment.
1. Moore FA, Moore EE. Evolving concepts in the pathogenesis of postinjury multiple organ failure. Surg Clin North Am 1995; 75: 257–77.
2. Moore FA, Sauaia A, Moore EE, et al. Postinjury multiple organ failure: a bimodal phenomenon. J Trauma 1996; 40: 501–10;Discussion 510–2.
3. Kirton OC, Windsor J, Wedderburn R, et al. Failure of splanchnic resuscitation in the acutely injured trauma patient correlates with multiple organ system failure and length of stay in the ICU. Chest 1998; 113: 1064–9.
4. Swank GM, Deitch EA. Role of the gut in multiple organ failure: bacterial translocation and permeability changes. World J Surg 1996; 20: 411–7.
5. Doglio GR, Pusajo JF, Egurrola MA, et al. Gastric mucosal pH as a prognostic index of mortality in critically ill patients. Crit Care Med 1991; 19: 1037–40.
6. Baker JW, Deitch EA, Li M, et al. Hemorrhagic shock induces bacterial translocation from the gut. J Trauma 1988; 28: 896–906.
7. Jakob SM, Ruokonen E, Vuolteenaho O, et al. Splanchnic perfusion during hemodialysis: evidence for marginal tissue perfusion. Crit Care Med 2001; 29: 1393–8.
8. Okano N, Miyoshi S, Owada R, et al. Impairment of hepatosplanchnic oxygenation and increase of serum hyaluronate during normothermic and mild hypothermic cardiopulmonary bypass. Anesth Analg 2002; 95: 278–86.
9. Jakob SM, Ruokonen E, Takala J. Assessment of the adequacy of systemic and regional perfusion after cardiac surgery. Br J Anaesth 2000; 84: 571–7.
10. Klein TF, Osmer C, Muller M, et al. The effect of a pre-operative infusion of Ringer’s solution on splanchnic perfusion in patients undergoing coronary artery bypass grafting. Anaesthesia 2002; 57: 756–60.
11. Mythen MG, Webb AR. Perioperative plasma volume expansion reduces the incidence of gut mucosal hypoperfusion during cardiac surgery. Arch Surg 1995; 130: 423–9.
12. Sakka SG, Meier-Hellman A, Reinhart K. Do fluid administration and reduction in norepinephrine dose improve global and splanchnic haemodynamics? Br J Anaesth 2000; 84: 758–62.
13. Wilkes NJ, Woolf R, Mutch M, et al. The effects of balanced versus saline-based hetastarch and crystalloid solutions on acid-base and electrolyte status and gastric mucosal perfusion in elderly surgical patients. Anesth Analg 2001; 93: 811–6;comment 809–10.
14. Treggiari MM, Romand JA, Burgener D, et al. Effect of increasing norepinephrine dosage on regional blood flow in a porcine model of endotoxin shock. Crit Care Med 2002; 30: 1334–9.
15. Kiefer P, Tugtekin I, Wiedeck H, et al. Hepato-splanchnic metabolic effects of the stable prostacyclin analogue iloprost in patients with septic shock. Intensive Care Med 2001; 27: 1179–86;comment 1110–2.
16. Bulkley GB, Kvietys PR, Perry MA, Granger DN. Effects of cardiac tamponade on colonic hemodynamics and oxygen uptake. Am J Physiol 1983; 244: G604–12.
17. Sapirstein LA, Sapirstein EH, Bredemeyer AS. Effect of hemorrhage on the cardiac output and its distribution in the rat. Circ Res 1960; 8: 130–9.
18. Vatner SF. Effects of hemorrhage on regional blood flow distribution in dogs and primates. J Clin Invest 1974; 54: 225–35.
19. Bailey RW, Bregman ML, Fuh KC, et al. Hemodynamic pathogenesis of ischemic hepatic injury following cardiogenic shock/resuscitation. Shock 2000; 14: 451–9.
20. Reilly PM, Wilkins KB, Fuh KC, et al. The mesenteric hemodynamic response to circulatory shock: an overview. Shock 2001; 15: 329–43.
21. Toung T, Reilly PM, Fuh KC, et al. Mesenteric vasoconstriction in response to hemorrhagic shock. Shock 2000; 13: 267–73.
22. Jakob SM, Tenhunen JJ, Laitinen S, et al. Effects of systemic arterial hypoperfusion on splanchnic hemodynamics and hepatic arterial buffer response in pigs. Am J Physiol Gastrointest Liver Physiol 2001; 280: G819–27.
23. Riddez L, Hahn RG, Brismar B, et al. Central and regional hemodynamics during acute hypovolemia and volume substitution in volunteers. Crit Care Med 1997; 25: 635–40.
24. Rowell LB, Blackmon JR, Kenny MA, Escourrou P. Splanchnic vasomotor and metabolic adjustments to hypoxia and exercise in humans. Am J Physiol 1984; 247: H251–8.
25. Khanna A, Rossman JE, Fung H-L, Caty MG. Intestinal and hemodynamic impairment following mesenteric ischemia/reperfusion. J Surg Res 2001; 99: 114–9.
26. Grotz MR, Ding J, Guo W, et al. Comparison of plasma cytokine levels in rats subjected to superior mesenteric artery occlusion or hemorrhagic shock. Shock 1995; 3: 362–8.
27. Ljungdahl M, Lundholm M, Katouli M, et al. Bacterial translocation in experimental shock is dependent on the strains in the intestinal flora. Scand J Gastroenterol 2000; 35: 389–97.
28. Bone RC. Toward an epidemiology and natural history of SIRS. JAMA 1992; 268: 3452–5.
29. Aranow JS, Fink MP. Determinants of intestinal barrier failure in critical illness. Br J Anaesth 1996; 77: 71–81.
30. Kistler EB, Lefer AM, Hugli TE, Schmid-Schönbein GW. Plasma activation during splanchnic arterial occlusion shock. Shock 2000; 14: 30–4.
31. Maynard N, Bihari D, Beale R, et al. Assessment of splanchnic oxygenation by gastric tonometry in patients with acute circulatory failure. JAMA 1993; 270: 1203–10.
32. Theodoropoulos G, Lloyd LR, Cousins G, Pieper D. Intraoperative and early postoperative gastric intramucosal pH predicts morbidity and mortality after major abdominal surgery. Am Surg 2001; 67: 303–8.
33. Poeze M, Takala J, Greve JW, Ramsay G. Pre-operative tonometry is predictive for mortality and morbidity in high-risk surgical patients. Intensive Care Med 2000; 26: 1272–81.
34. Granger DN, Richardson PDI, Kvietys PR, Mortillaro NA. Intestinal blood flow. Gastroenterology 1980; 78: 837–63.
35. Peach MJ. Renin-angiotensin system: biochemistry and mechanisms of action. Physiol Rev 1977; 57: 313–70.
36. McNeill JR, Stark RD, Greenway C. Intestinal vasoconstriction after hemorrhage: role of vasopressin and angiotensin. Am J Physiol 1970; 219: 1342–7.
37. Clozel M, Clozel JP. Effects of endothelin on regional blood flow in squirrel monkeys. J Pharmacol Exp Ther 1989; 250: 1125–31.
38. Bailey RW, Bulkley GB, Hamilton SR, et al. The fundamental hemodynamic mechanism underlying gastric “stress ulceration” in cardiogenic shock. Ann Surg 1987; 205: 597–612.
39. Bailey RW, Bulkley GB, Hamilton SR, et al. Protection of the small intestine from nonocclusive mesenteric ischemic injury due to cardiogenic shock. Am J Surg 1987; 153: 108–16.
40. Bailey RW, Bulkley GB, Hamilton SR, et al. Pathogenesis of nonocclusive ischemic colitis. Ann Surg 1986; 203: 590–9.
41. Bulkley GB, Oshima A, Bailey RW. Pathophysiology of hepatic ischemia in cardiogenic shock. Am J Surg 1986; 151: 87–97.
42. Aneman A, Pettersson A, Eisenhofer G, et al. Sympathetic and renin-angiotensin activation during graded hypovolemia in pigs: impact on mesenteric perfusion and duodenal mucosal function. Shock 1997; 8: 378–84.
43. Broome M, Aneman A, Haney M, et al. Angiotensin II mesenteric and renal vasoregulation: dissimilar modulatory effects with nitroprusside. Acta Anaesthesiol Scand 2000; 44: 1238–45.
44. Lautt WW. Mechanism and role of intrinsic regulation of hepatic arterial blood flow: the hepatic arterial buffer response. Am J Physiol 1985; 249: G549–56.
45. Mathie RT, Blumgart LH. The hepatic haemodynamic response to acute portal venous blood flow reductions in the dog. Pflugers Arch 1983; 399: 223–7.
46. Ayuse T, Brienza N, O’Donnell CP, Robotham JL. Pressure-flow analysis of portal vein and hepatic artery interactions in porcine liver. Am J Physiol 1994; 267: H1233–42.
47. Lautt WW. The 1995 Ciba-Geigy Award Lecture: intrinsic regulation of hepatic blood flow. Can J Physiol Pharmacol 1996; 74: 223–33.
48. Lautt WW, McQuaker JE. Maintenance of hepatic arterial blood flow during hemorrhage is mediated by adenosine. Can J Physiol Pharmacol 1989; 67: 1023–8.
49. Lautt WW, D’Almeida MS, McQuaker J, D’Aleo L. Impact of the hepatic arterial buffer response on splanchnic vascular responses to intravenous adenosine, isoproterenol, and glucagon. Can J Physiol Pharmacol 1988; 66: 807–13.
50. Lautt WW, Legare DJ, Ezzat WR. Quantitation of the hepatic arterial buffer response to graded changes in portal blood flow. Gastroenterology 1990; 98: 1024–8.
51. Ayuse T, Brienza J, Revelly P, et al. Role of nitric oxide in porcine liver circulation under normal and endotoxemic conditions. J Appl Physiol 1995; 78: 1319–29.
52. Schiffer ER, Mentha G, Schwieger IM, Morel DR. Sequential changes in the splanchnic circulation during continuous endotoxin infusion in sedated sheep: evidence for a selective increase of hepatic artery blood flow and loss of the hepatic arterial buffer response. Acta Physiol Scand 1993; 147: 251–61.
53. Richter S, Olinger A, Hildebrandt U. Loss of physiologic hepatic blood flow control (“hepatic arterial buffer response”) during CO2
-pneumoperitoneum in the rat. Anesth Analg 2001; 93: 872–7.
54. Hiltebrand LB, Krejci V, Banic A, et al. Dynamic study of the distribution of microcirculatory blood flow in multiple splanchnic organs in septic shock. Crit Care Med 2000; 28: 3233–41.
55. Edouard AR, Degremont AC, Duranteau J, et al. Heterogeneous regional vascular responses to simulated transient hypovolemia in man. Intensive Care Med 1994; 20: 414–20.
56. Rasmussen A, Skak C, Kristensen M, et al. Preserved arterial flow secures hepatic oxygenation during haemorrhage in the pig. J Physiol 1999; 516: 539–48.
57. Ruokonen E, Takala J, Kari A. Regional blood flow and oxygen transport in patients with the low cardiac output syndrome after cardiac surgery. Crit Care Med 1993; 21: 1304–11.
58. Parviainen I, Ruokonen E, Takala J. Dobutamine-induced dissociation between changes in splanchnic blood flow and gastric intramucosal pH after cardiac surgery. Br J Anaesth 1995; 74: 277–82.
59. Uusaro A, Ruokonen E, Takala J. Gastric mucosal pH does not reflect changes in splanchnic blood flow after cardiac surgery. Br J Anaesth 1995; 74: 149–54.
60. Kleen M, Habler O, Hutter J, et al. Effects of hemodilution on splanchnic perfusion and hepatorenal function. I. Splanchnic perfusion. Eur J Med Res 1997; 2: 413–8.
61. Habler O, Kleen M, Hutter J, et al. Effects of hemodilution on splanchnic perfusion and hepatorenal function. II. Renal perfusion and hepatorenal function. Eur J Med Res 1997; 2: 419–24.
62. Huang HS, Longhurst JC. Cardiovascular reflexes during abdominal ischemia in cats. Am J Physiol 1994; 267: R97–106.
63. Longhurst JC, Rotto DM, Kaufman MP, Stahl GL. Ischemically sensitive abdominal visceral afferents: response to cyclooxygenase blockade. Am J Physiol 1991; 261 (6 Pt 2): H2075–81.
64. Rendig SV, Premjit SC, Longhurst JC. Cardiovascular reflex responses to ischemia during occlusion of celiac and/or superior mesenteric arteries. Am J Physiol 1997; 272: H791–6.
65. Schlichting E, Lyberg T. Monitoring of tissue oxygenation in shock: an experimental study in pigs. Crit Care Med 1995; 23: 1703–10.
66. Heino A, Hartikainen J, Merasto ME, et al. Systemic and regional pCO2
gradients as markers of intestinal ischaemia. Intensive Care Med 1998; 24: 599–604.
67. Jakob SM, Tenhunen JJ, Heino A, et al. Splanchnic vasoregulation during mesenteric ischemia and reperfusion in pigs. Shock 2002; 18: 142–7.
68. Seeto RK, Fenn B, Rockey DC. Ischemic hepatitis: clinical presentation and pathogenesis. Am J Med 2000; 109: 109–13.
69. Henrion J, Descamps O, Luwaert R, et al. Hypoxic hepatitis in patients with cardiac failure: incidence in a coronary care unit and measurement of hepatic blood flow. J Hepatol 1994; 21: 696–703.
70. Brander L, Knuesel R, Takala J, Jakob SM. A new experimental model for the assessment of splanchnic blood flow regulation. Intensive Care Med 2001; 27 (Suppl): S220.
71. Knuesel R, Jakob SM, Brander L, Takala J. Haldane effect and varying metabolism invalidate the use of pCO2
-gradients for the assessment of blood flow changes. Intensive Care Med 2001; 27 (Suppl): S220.
72. Krejci V, Hiltebrand L, Banic A, et al. Continuous measurements of microcirculatory blood flow in gastrointestinal organs during acute haemorrhage. Br J Anaesth 2000; 84: 468–75.
73. Kirklin JK, Kirklin JW. Cardiopulmonary bypass for cardiac surgery. In: Sabiston DC Jr, Spencer FC, eds. Surgery of the chest. 5th ed. Philadelphia: WB Saunders, 1990: 1107–25.
74. Cremer J, Martin M, Redl H, et al. Systemic inflammatory response syndrome after cardiac operations. Ann Thorac Surg 1996; 61: 1714–20.
75. Elgebaly SA, Houser SL, El Kerm AF, et al. Evidence of cardiac inflammation after open heart operations. Ann Thorac Surg 1994; 57: 391–6.
76. Ohri SK, Bowles CW, Mathie RT, et al. Effect of cardiopulmonary bypass perfusion protocols on gut tissue oxygenation and blood flow. Ann Thorac Surg 1997; 64: 163–70.
77. Riddington DW, Venkatesh B, Boivin CM, et al. Intestinal permeability, gastric intramucosal pH, and systemic endotoxemia in patients undergoing cardiopulmonary bypass. JAMA 1996; 275: 1007–12.
78. Sinclair DG, Haslam PL, Quinlan GJ, et al. The effect of cardiopulmonary bypass on intestinal and pulmonary endothelial permeability. Chest 1995; 108: 718–24.
79. Dunn J, Kirsh MM, Harness J, et al. Hemodynamic, metabolic, and hematologic effects of pulsatile cardiopulmonary bypass. J Thorac Cardiovasc Surg 1974; 68: 138–47.
80. Taylor KM, Bain WH, Morton JJ. The role of angiotensin II in the development of peripheral vasoconstriction during open-heart surgery. Am Heart J 1980; 100: 935–7.
81. Hampton WW, Townsend MC, Schirmer WJ, et al. Effective hepatic blood flow during cardiopulmonary bypass. Arch Surg 1989; 124: 458–9.
82. Tao W, Zwischenberger JB, Nguyen TT, et al. Gut mucosal ischemia during normothermic cardiopulmonary bypass results from blood flow redistribution and increased oxygen demand. J Thorac Cardiovasc Surg 1995; 110: 819–28.
83. Ohri SK, Becket J, Brannan J, et al. Effects of cardiopulmonary bypass on gut blood flow, oxygen utilization, and intramucosal pH. Ann Thorac Surg 1994; 57: 1193–9.
84. Revelly JP, Tappy L, Berger MM, et al. Early metabolic and splanchnic responses to enteral nutrition in postoperative cardiac surgery patients with circulatory compromise. Intensive Care Med 2001; 27: 540–7.
85. Dahn MS, Lange P, Lobdell K, et al. Splanchnic and total body oxygen consumption differences in septic and injured patients. Surgery 1987; 101: 69–80.
86. Dahn MS, Lange MP, Wilson RF, et al. Hepatic blood flow and splanchnic oxygen consumption measurements in clinical sepsis. Surgery 1990; 107: 295–301.
87. Ruokonen E, Takala J, Kari A, et al. Regional blood flow and oxygen transport in septic shock. Crit Care Med 1993; 21: 1296–303.
88. Dahn MS, Mitchell RA, Lange MP, et al. Hepatic metabolic response to injury and sepsis. Surgery 1995; 117: 520–30.
89. Reinelt H, Radermacher P, Fischer G, et al. Effects of a dobutamine-induced increase in splanchnic blood flow on hepatic metabolic activity in patients with septic shock. Anesthesiology 1997; 86: 818–24.
90. Halvorsen L, Roth R, Gunther RA, et al. Liver hemodynamics during portal venous endotoxemia in swine. Circ Shock 1993; 41: 166–75.
91. Ayuse T, Brienza N, Revelly JP, et al. Alterations in liver hemodynamics in an intact porcine model of endotoxin shock. Am J Physiol 1995; 268: H1106–14.
92. Creteur J, De Backer D, Vincent JL. A dobutamine test can disclose hepatosplanchnic hypoperfusion in septic patients. Am J Respir Crit Care Med 1999; 160: 839–45.
93. Dziki AJ, Lynch WH, Ramsey CB, Law WR. Beta-adrenergic-dependent and -independent actions of naloxone on perfusion during endotoxin shock. Circ Shock 1993; 39: 29–38.
94. Zhang H, Smail N, Cabral A, et al. Hepatosplanchnic blood flow and oxygen extraction capabilities during experimental tamponade: effects of endotoxin. J Surg Res 1999; 81: 129–38.
95. Kincaid EH, Miller PR, Meredith JW, Chang MC. Enalaprilat improves gut perfusion in critically injured patients. Shock 1998; 9: 79–83.
96. Reinelt H, Radermacher P, Kiefer P, et al. Impact of exogenous beta-adrenergic receptor stimulation on hepatosplanchnic oxygen kinetics and metabolic activity in septic shock. Crit Care Med 1999; 27: 325–31.
97. Jakob SM, Ruokonen E, Takala J. Effects of dopamine on systemic and regional blood flow and metabolism in septic and cardiac surgery patients. Shock 2002; 18: 8–13.
98. Guzman JA, Rosado AE, Kruse JA. Dopamine-1 receptor stimulation attenuates the vasoconstrictive response to gut ischemia. J Appl Physiol 2001; 91: 596–602.
99. Kern H, Schröder T, Kaulfuss M, et al. Enoximone in contrast to dobutamine improves hepatosplanchnic function in fluid-optimized septic shock patients. Crit Care Med 2001; 29: 1519–25.
100. Agusti M, Elizalde JI, Adalia R, et al. The effects of vasoactive drugs on hepatic blood flow changes induced by CO2
laparoscopy: an animal study. Anesth Analg 2001; 93: 1121–6.
101. Richards WO, Scovill W, Shin B, Reed W. Acute renal failure associated with increased intra-abdominal pressure. Ann Surg 1983; 197: 183–7.
102. Landgarten MJ, Kumar A, Parrillo JE. Cardiovascular dysfunction in sepsis and septic shock. Curr Treat Options Cardiovasc Med 2000; 2: 451–9.
103. Day NP, Phu NH, Bethell DP, et al. The effects of dopamine and adrenaline infusions on acid-base balance and systemic haemodynamics in severe infection. Lancet 1996; 348: 219–23.
104. Clemmesen JO, Galatius S, Skak C, et al. The effect of increasing blood pressure with dopamine on systemic, splanchnic, and lower extremity hemodynamics in patients with acute liver failure. Scand J Gastroenterol 1999; 34: 921–7.
105. Ben-Shachar D, Zuk R, Glinka Y. Dopamine neurotoxicity: inhibition of mitochondrial respiration. J Neurochem 1995; 64: 718–23.
106. Muller M, Boldt J, Schindler E, et al. Effects of low-dose dopexamine on splanchnic oxygenation during major abdominal surgery. Crit Care Med 1999; 27: 2389–93.
107. Burgener D, Laesser M, Treggiari-Venzi M, et al. Endothelin-1 blockade corrects mesenteric hypoperfusion in a porcine low cardiac output model. Crit Care Med 2001; 29: 1615–20.
108. LeDoux D, Astiz ME, Carpati CM, Rackow EC. Effects of perfusion pressure on tissue perfusion in septic shock. Crit Care Med 2000; 28: 2729–32.
109. Wenzel V, Lindner KH, Krismer AC, et al. Repeated administration of vasopressin but not epinephrine maintains coronary perfusion pressure after early and late administration during prolonged cardiopulmonary resuscitation in pigs. Circulation 1999; 99: 1379–84.
110. Lindner KH, Brinkmann A, Pfenninger EG, et al. Effect of vasopressin on hemodynamic variables, organ blood flow, and acid-base status in a pig model of cardiopulmonary resuscitation. Anesth Analg 1993; 77: 427–35.
111. Luce JM, Rizk NA, Niskanen RA. Regional blood flow during cardiopulmonary resuscitation in dogs. Crit Care Med 1984; 12: 874–8.
112. Prengel AW, Lindner KH, Wenzel V, et al. Splanchnic and renal blood flow after cardiopulmonary resuscitation with epinephrine and vasopressin in pigs. Resuscitation 1998; 38: 19–24.
113. Hansen EF, Strandberg C, Hojgaard L, et al. Splanchnic haemodynamics after intravenous terlipressin in anaesthetised healthy pigs. J Hepatol 1999; 30: 503–10.
114. Lee WC, Lin HC, Yang YY, et al. Hemodynamic effects of a combination of prazosin and terlipressin in patients with viral cirrhosis. Am J Gastroenterol 2001; 96: 1210–6.
Submit Your Papers Online
You can now have your paper processed and reviewed faster by sending it to us through our new, web-based Rapid Review System.
Submitting your manuscript online will mean that the time and expense of sending papers through the mail can be eliminated. Moreover, because our reviewers will also be working online, the entire review process will be significantly faster.
You can submit manuscripts electronically via http://www.rapidreview.com. There are links to this site from the Anesthesia & Analgesia website (http://www.anesthesia-analgesia.org), and the IARS website (http://www.iars.org).
To find out more about Rapid Review, go to http://www.rapidreview.com and click on “About Rapid Review.”
This article has been cited 1 time(s).
Pediatric Surgery InternationalSplanchnic-cerebral oxygenation ratio (SCOR) values in healthy term infants as measured by near-infrared spectroscopy (NIRS)Pediatric Surgery International
© 2003 International Anesthesia Research Society
What does "Remember me" mean?
By checking this box, you'll stay logged in until you logout. You'll get easier access to your articles, collections,
media, and all your other content, even if you close your browser or shut down your
To protect your most sensitive data and activities (like changing your password),
we'll ask you to re-enter your password when you access these services.
What if I'm on a computer that I share with others?
If you're using a public computer or you share this computer with others, we recommend
that you uncheck the "Remember me" box.
Data is temporarily unavailable. Please try again soon.
Readers Of this Article Also Read